-- T2 Metals (TWO.V) 周三宣布，已完成最后一期非经纪人私募配售，募集资金 6.8 万美元。 该公司表示，此次配售共发行 13.6 万份单位，每份单位定价 0.50 美元，包含一股普通股和半份两年期认股权证，持有该认股权证可以 0.75 美元的价格购买一股普通股。 此次融资，该公司共发行 1490 万份单位，募集资金 740 万美元。 该公司股票在多伦多证券交易所创业板 (TSX Venture Exchange) 的最新报收于 0.475 美元，下跌 0.025 美元。
Price: $0.48, Change: $-0.03, Percent Change: -5.00%
National Australia Bank (ASX:NAB) shares were down about 1% in recent Monday trade following a Friday settlement with the Finance Sector Union of Australia to resolve court proceedings related to excessive additional working hours for employees.The settlement, reached on a without-admissions basis through mediation, includes the establishment of a health, safety, and well-being framework to mitigate the risks linked to working additional hours, and calls for greater oversight of such risks.The union and the bank said in a joint statement that they are "committed to continuing to work together to ensure fair and sustainable outcomes for all [National Australia Bank] employees."
Clinuvel Pharmaceuticals (ASX:CUV) said the US Food and Drug Administration (FDA) removed a requirement for a post-authorization phase one study on cardiac repolarization in relation to its Scenesse implant upon reviewing its long-term safety profile, according to a Monday filing with the Australian bourse.Scenesse is used to treat patients with erythropoietic protoporphyria, a disease that causes intolerance to light.The FDA concluded that the study was no longer needed since it would not yield valuable safety information, the filing said.
XRF Scientific (ASX:XRF) has completed the acquisition of the combustion gas analysis business from Bruker AXS, according to a Monday Australian bourse filing.The company entered a binding agreement to acquire the combustion gas analysis business for $4 million upfront plus a potential $1 million earnout based on 7% of net revenue over three years, an earlier filing showed.